WallStreetZenWallStreetZen

NASDAQ: LMDX
Lumiradx Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for LMDX

Based on 3 analysts offering 12 month price targets for Lumiradx Ltd.
Min Forecast
$0.75+248.84%
Avg Forecast
$1.42+559.07%
Max Forecast
$2.70+1,155.81%

Should I buy or sell LMDX stock?

Based on 3 analysts offering ratings for Lumiradx Ltd.
Buy
Strong Buy
1 analysts 33.33%
Buy
1 analysts 33.33%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their LMDX stock forecasts and price targets.

LMDX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Raymond James
Bottom 2%
2
BuyMaintains$0.80+272.09%2023-08-28
Ladenburg Thalmann
Bottom 1%
1
Strong BuyMaintains$2.70+1,155.81%2023-05-17
Goldman Sachs
Bottom 4%
4
HoldMaintains$0.75+248.84%2023-05-17

1 of 1

Forecast return on equity

Is LMDX forecast to generate an efficient return?
Company
-62.41%
Industry
-19.56%
Market
48.56%
LMDX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is LMDX forecast to generate an efficient return on assets?
Company
-39.3%
Industry
11.28%
LMDX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

LMDX revenue growth forecast

How is LMDX forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
81.4%
Industry
5.5%
Market
12.79%
LMDX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
LMDX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

LMDX vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
LMDX$0.22$1.42+559.07%Buy
ENZ$1.39N/AN/A
MDXH$2.56$7.00+173.44%Strong Buy
GTH$0.79N/AN/A
PRPH$4.38$14.00+219.63%Buy
View Top Diagnostic & Research Stocks

Lumiradx Stock Forecast FAQ

Is Lumiradx Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: LMDX) stock is to Buy LMDX stock.

Out of 3 analysts, 1 (33.33%) are recommending LMDX as a Strong Buy, 1 (33.33%) are recommending LMDX as a Buy, 1 (33.33%) are recommending LMDX as a Hold, 0 (0%) are recommending LMDX as a Sell, and 0 (0%) are recommending LMDX as a Strong Sell.

If you're new to stock investing, here's how to buy Lumiradx stock.

What is LMDX's forecast return on equity (ROE) for 2023-2024?

(NASDAQ: LMDX) forecast ROE is -62.41%, which is considered weak.

What is LMDX's Price Target?

According to 3 Wall Street analysts that have issued a 1 year LMDX price target, the average LMDX price target is $1.42, with the highest LMDX stock price forecast at $2.70 and the lowest LMDX stock price forecast at $0.75.

On average, Wall Street analysts predict that Lumiradx's share price could reach $1.42 by Aug 28, 2024. The average Lumiradx stock price prediction forecasts a potential upside of 559.07% from the current LMDX share price of $0.22.

What is LMDX's forecast return on assets (ROA) for 2023-2024?

(NASDAQ: LMDX) forecast ROA is -39.3%, which is lower than the forecast US Diagnostics & Research industry average of 11.28%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.